Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1000 new staffers over ...

Retrieved on: 2021-07-16 15:33:45

Tags for this article:

Drugs

Health sciences

Health care

Monoclonal antibodies

Antiviral drugs

COVID-19 drug development

Regeneron Pharmaceuticals

Leonard Schleifer

Sanofi

Bamlanivimab/etesevimab

Bamlanivimab

Casirivimab/imdevimab

Click the tags to see associated articles and topics

Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1000 new staffers over .... View article details on HISWAI: https://www.fiercebiotech.com/biotech/regeneron-eyes-1-8b-r-d-upgrade-at-tarrytown-campus-where-it-plans-to-enlist-1-000-new

Excerpt

The company, which gained national prominence for its COVID-19 antibody research, laid plans ... Regeneron's drug snagged the silver right behind Eli Lilly's monoclonal antibody drug bamlanivimab, but since then, the tables have ...

Article found on: www.fiercebiotech.com

View Original Article